Complete nucleotide sequences of R69, R471, p202c and KPN-El.Nr.7 have been deposited into the EMBL database under EMBL accession numbers KM406488, KM406489, KM406490, KM406491, respectively.

Introduction {#sec005}
============

IncL/M is currently one of the six major resistance plasmid families identified in clinically relevant *Enterobacteriaceae*, together with IncF, IncA/C, IncI, IncHI, and IncN \[[@pone.0123063.ref001]\]. IncL/M-type plasmids have been identified in association with antibiotic resistance genes encoding extended-spectrum β-lactamases (ESBL) (*bla* ~CTX-M-3~, *bla* ~SHV-5~), class A, B and D carbapenemases (*bla* ~KPC~, *bla* ~IMP~, *bla* ~NDM~, and *bla* ~OXA-48~), AmpC β-lactamases (*bla* ~FOX-7~), as well as with the *armA* 16S rRNA methylase gene, conferring resistance to all aminoglycosides \[[@pone.0123063.ref002]--[@pone.0123063.ref011]\]. In particular, a unique epidemic IncL/M-type plasmid (pOXA-48) is at the origin of the worldwide dissemination of *bla* ~OXA-48~ \[[@pone.0123063.ref009]\].

In previous studies, the comparative analysis of the variable region of fully sequenced IncL/M plasmids identified mobile elements that contributed to the acquisition of resistance genes, but scarce attention was paid to the plasmid backbones. However, it was noticed that the epidemic pOXA-48 plasmid showed significant backbone homology with other IncL/M plasmids except for three genes (*traX*, *traY* and *excA*) \[[@pone.0123063.ref007]\].

The target (ExcA) and exclusion (TraY) proteins are part of the so called "*entry exclusion system*" of conjugative plasmids \[[@pone.0123063.ref012]\]. During bacterial conjugation, plasmid DNA is transferred into a recipient cell via cell-to-cell contact. Transfer may be inhibited when donor and recipient cells harbor closely related conjugative plasmids. The interaction of ExcA in the recipient cell with its cognate TraY in the donor cell is one of the mechanisms that impairs the conjugation and inhibits redundant DNA transfer. Therefore, two cells carrying plasmids with different ExcA-TraY proteins should be able to successfully conjugate \[[@pone.0123063.ref013]\]. Furthermore, TraX is the presumptive relaxase of the plasmid and its DNA sequences have been used as molecular markers for plasmid classification \[[@pone.0123063.ref014]\]. Therefore, plasmids showing different *traX* genes should be classified in different phylogenetic groups.

Based on these observations, we hypothesized that there are two different plasmid types in the IncL/M family. This was also supposed in the 70s', when two different groups (i.e., IncL and IncM) were initially defined by incompatibility tests performed by conjugation \[[@pone.0123063.ref015]\]. Later, in the early 80s', IncL and IncM plasmids were combined into the IncL/M group, due to their high-level of DNA homology \[[@pone.0123063.ref016],[@pone.0123063.ref017]\].

Because of the clinical and epidemiological relevance of these plasmid families, we fully sequenced the reference plasmids R471 and R69 formerly assigned by incompatibility assays to the IncL and IncM groups, respectively. Two recently isolated IncL/M plasmids carrying *bla* ~SHV-5~ or *bla* ~OXA-48~ were also fully sequenced for comparative analysis.

Based on the plasmid genome and conjugative properties of the plasmids, the present work re-defines the structure of the IncL and IncM families and assigns the fully sequenced IncL/M plasmids available in GenBank to their corresponding groups.

Materials and Methods {#sec006}
=====================

Bacterial strains {#sec007}
-----------------

Plasmids R69 and R471 were from the collection of reference plasmids used for incompatibility testing available at the Istituto Superiore di Sanità, Rome, Italy \[[@pone.0123063.ref018]\]. Plasmid R69 was isolated in 1970 from *Salmonella paratyphi* B in France and assigned to the compatibility group com7, also named IncM \[[@pone.0123063.ref019]\]. Plasmid R471 was isolated in 1977 from *Serratia marcescens* in the USA and initially assigned to IncL, then re-classified as IncM \[[@pone.0123063.ref015],[@pone.0123063.ref016]\]. Plasmid p202c was identified in *S*. *enterica* Typhimurium in 1985 in Albania and assigned to IncL/M group \[[@pone.0123063.ref003]\] by Southern blot hybridization \[[@pone.0123063.ref017]\] and PCR-Based Replicon Typing (PBRT; \[[@pone.0123063.ref018]\]). Plasmid pKPN-El-Nr.7 was isolated from *Klebsiella pneumoniae* AE-2247421 in 2013 in Switzerland \[[@pone.0123063.ref020]\] and assigned to IncL/M using the *repA* PCR devised on the pOXA-48 plasmid \[[@pone.0123063.ref009]\]. Plasmid pNDM-OM was identified in *K*. *pneumoniae* in 2010 in the Sultanate of Oman and fully sequenced \[[@pone.0123063.ref007]\] ([Table 1](#pone.0123063.t001){ref-type="table"}).

10.1371/journal.pone.0123063.t001

###### Fully sequenced plasmids belonging to the IncL and IncM families analyzed in this study.

![](pone.0123063.t001){#pone.0123063.t001g}

  Plasmid name   Plasmid size (base pairs)   GenBank Acc. No.       Resistance gene(s) on plasmid                                                                Inc group [^a^](#t001fn001){ref-type="table-fn"}   Plasmid core genome (nucleotide positions)   Plasmid core genome (length in base pairs)
  -------------- --------------------------- ---------------------- -------------------------------------------------------------------------------------------- -------------------------------------------------- -------------------------------------------- --------------------------------------------
  pKPN-El-Nr.7   63,581                      This study: KM406491   *bla* ~OXA-48~                                                                               IncL                                               971--33389;58247--62497                      36,668
  pE71T          63,578                      KC335143               *bla* ~OXA-48~                                                                               IncL                                               26221--59607; 25453--20887                   37,952
  pKPoxa-48N1    62,592                      NC_021488              *bla* ~OXA-48~                                                                               IncL                                               1--26200;51044--62592                        37,748
  pKPoxa-48N2    167,203                     NC_021502              *bla* ~OXA-48~                                                                               IncL                                               1--26200; 155651--167230                     37,748
  pOXA48         61,881                      NC_019154              *bla* ~OXA-48~                                                                               IncL                                               19660--57449                                 37,789
  R830b          81,793                      NC_019344              *merA*                                                                                       IncL                                               32333--68829                                 36,496
  R471           86,748                      This study: KM406489   *bla* ~TEM-1~, *merA*                                                                        IncL                                               61219--86748;1--10968                        36,497
  pCTX-M3        89,168                      NC_004464              *bla* ~CTX-M-3~, *armA*, *dfrA12*, *aacC2*, *aadA2*, *sul1*, *mph*(E), *bla* ~TEM-1~         IncM2                                              18187--55934                                 37,747
  pCTX-M360      68,018                      NC_011641              *bla* ~CTX-M-3~, *bla* ~TEM-1~                                                               IncM2                                              1--26214; 56602--68018                       37,630
  pEl1573        87,731                      NC_019368              *bla* ~IMP-4~, *bla* ~TEM-1~, *aacA4*, *catB3*, *mph*(A), *aacC2*, *qacG*, *sul1*, *qnrB2*   IncM2                                              15129--52921                                 37,792
  pNDM-HK        83,803                      NC_019063              *bla* ~NDM-1~, *bla* ~TEM-1~, *aacC2*, *armA*, *Δbla* ~DHA-1~, *mph*(E), *sul1*              IncM2                                              52321--88803; 1--1594                        38,076
  pNDM-OM        87,185                      NC_019889              *bla* ~NDM-1~, *bla* ~TEM-1~, *aacC2*, *armA*, *Δbla* ~DHA-1~, *mph*(E), *sul1*              IncM2                                              975--39051                                   38,076
  p202c          79,502                      This study: KM406490   *bla* ~SHV-5~, *tetA*(A), *aacC1*, *aacA4*, *aadA1*, *merA*                                  IncM1                                              4430--40962                                  36,532
  pEL60          60,145                      AY422214               No resistance genes                                                                          IncM1                                              14746--53148                                 38,402
  R69            78,899                      This study: KM406488   *bla* ~TEM-1~, *tetA*(B), *aphA-1*, *merA*                                                   IncM1                                              11238--47808                                 36,570
  pNE1280        66,531                      NC_019346              *bla* ~KPC-4~                                                                                IncM1                                              1-2418655671-66531                           35,046
  pFOX-7a        90,439                      HG934082               *bla* ~FOX-7~, *bla* ~TEM-1~, *aacA4*, *sul1*, *merA*                                        IncM1                                              1373--2983; 7932--44137                      37,817

^a^ According to the new PBRT strategy proposed in this work.

All plasmids sequenced in this study were previously transferred into *E*. *coli* K12 strains by conjugation or transformation \[[@pone.0123063.ref003], [@pone.0123063.ref007], [@pone.0123063.ref020]\]. Plasmids R69 and R471 confer resistance to ampicillin/tetracycline/kanamycin and ampicillin, respectively. Plasmid p202c confers resistance to third-generation cephalosporins by the presence of the *bla* ~SHV-5~ ESBL gene and carries further resistance determinants, including the In-t3 class 1 integron, containing aminoglycoside resistance gene cassettes \[[@pone.0123063.ref003], [@pone.0123063.ref021]\]. Plasmids pKPN-El-Nr.7 \[[@pone.0123063.ref020]\] and pNDM-OM \[[@pone.0123063.ref007]\] confer carbapenem resistance due to the expression of the *bla* ~OXA-48~ and *bla* ~NDM-1~ genes, respectively.

Incompatibility assays {#sec008}
----------------------

Incompatibility assays were performed crossing R69 x pKPN-El.Nr.7 and R69 x pNDM-OM *E*. *coli* transformants on solid Luria-Bertani (LB) agar plates without antibiotics. R69 x pKPN-El-Nr.7 transconjugants were selected on LB agar containing 50 μg/ml of kanamycin and 0.5 μg/ml of imipenem. Selected transconjugants were analyzed by plasmid DNA purification (see below).

Fourteen transconjugants were also tested for stability, by sub-cultivation in LB liquid medium without antibiotics for three days. An aliquot of each culture was plated daily on LB agar plates containing either no antibiotics, or containing 0.5 μg/ml of imipenem, or 50 μg/ml of kanamycin, or both 0.5 μg/ml imipenem and 50 μg/ml kanamycin. Fifty colonies from LB agar plates containing no antibiotics were screened for the presence of the IncL and IncM plasmids by PBRT (see below).

The R69 x pNDM-OM conjugation was first incubated 45 min at 37°C in 2 ml LB containing 1 μg/ml of tetracycline for the induction of the tetracycline resistant phenotype \[[@pone.0123063.ref022]\]. Appropriate dilutions of the induced cultures were then selected on solid LB agar plates containing 20 μg/ml of tetracycline and 0.5 μg/ml of imipenem.

Restriction analysis of plasmid DNAs {#sec009}
------------------------------------

R69, pKPN-El-Nr.7 and transconjugant plasmid DNAs were purified by the Genopure Plasmid Midi Kit (Roche Diagnostic, GmbH, Mannheim, Denmark) following the manufacturer's protocol. Plasmid DNA was analyzed as undigested (data not shown) or restricted with BamHI, EcoRI and EcoRV (Bioconcept, Allschwil, Switzerland). Restriction patterns were analyzed on 0.8% agarose gel electrophoresis.

Plasmid DNA sequencing {#sec010}
----------------------

Complete DNA sequences of R69, R471, p202c and pKPN-El-Nr.7 were obtained following the 454-Junior Genome Sequencer procedure (Roche Diagnostic) on plasmid libraries. Plasmid DNA was purified from the respective *E*. *coli* transformants by the Genopure Plasmid Midi Kit (Roche Diagnostic).

De novo assembly of DNA reads and gap-closure {#sec011}
---------------------------------------------

Contigs with at least a 50-fold coverage were obtained using the GS-FLX gsAssembler software. Contigs were firstly assembled *in silico* by the 454 ReadStatus output file, generated by the gsAssembler software (Roche Diagnostics), identifying reads overlapping adjacent contigs. Contigs assembly and predicted gaps were then confirmed and filled by PCR-based gap closure by Sanger DNA sequencing of the amplicons.

Annotation {#sec012}
----------

Protein prediction was performed with Artemis Version 8 (Sanger Institute). Pairwise alignment was performed by a BLASTN and BLASTP homology search (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>).

Phylogenetic analysis of IncL/M plasmids {#sec013}
----------------------------------------

Homology and phylogenetic trees were obtained by aligning the IncL/M DNA sequences listed in [Table 1](#pone.0123063.t001){ref-type="table"}. For the comparative analysis of the plasmid backbone, a core genome sequence was obtained as follows: for each plasmid, DNA sequences shared by all the IncL/M plasmids were identified by BLASTN and jointed to form a co-linear sequence of approximately 38 Kb, whose boundaries are indicated in [Table 1](#pone.0123063.t001){ref-type="table"}. The alignment of core genomes was generated using the DNAMAN phylogenetic analysis software (Lynnon BioSoft, Vaudreuil, Quebec, Canada), for Quick Alignment. Unrooted phylogenetic trees were generated by the Maximum Likelihood method.

PBRT update for the IncL and IncM plasmid families {#sec014}
--------------------------------------------------

IncL PBRT was performed using the L- FW (5\'- CGG AAC CGA CAT GTG CCT ACT -3\') and L/M- RV (5\'- GAA CTC CGG CGA AAG ACC TTC-3\') primer pair. The IncM PBRT was performed using M-FW (5\'- GGA TGA AAA CTA TCA GCA TCT GAA G -3\') and L/M- RV (5\'- GAA CTC CGG CGA AAG ACC TTC-3\') primers. The expected amplicons were 854 bp for the IncL and 738 bp for the IncM plasmids, respectively. The IncM forward primer is that previously reported in the IncL/M PBRT \[[@pone.0123063.ref018]\].

The PCR conditions were as follows: 1 cycle of denaturation at 94°C for 10 minutes, followed by 30 cycles of denaturation at 95°C for 1 minute, annealing at 60°C for 30 seconds and elongation at 72°C for 1 minute, followed by 1 cycle at 72°C for 5 minutes.

The IncL/M-RV primer was used for sequencing the PBRT amplicon, determining the IncM1 and IncM2 *inc*RNA type.

Nucleotide sequence accession numbers {#sec015}
-------------------------------------

Complete nucleotide sequences of R69, R471, p202c and pKPN-El-Nr.7 have been deposited into the EMBL database under EMBL accession numbers KM406488, KM406489, KM406490, KM406491, respectively.

Results and Discussion {#sec016}
======================

Plasmid incompatibility assay {#sec017}
-----------------------------

Incompatibility assays were performed using the *E*. *coli* transformants obtained from the IncM reference plasmid R69 and the *bla* ~OXA-48~-positive pKPN-El-Nr.7 plasmid \[[@pone.0123063.ref020]\]. Transconjugants were obtained at very high frequency (2 x 10^-3^ transconjugants per donor cell). Plasmid DNAs of R69, pKPN-El-Nr.7 and one of the transconjugants were purified and restricted with BamHI, EcoRI and EcoRV. As expected, the transconjugant produced restriction patterns compatible with the co-presence of R69 and pKPN-El-Nr.7 in the same cell ([Fig 1](#pone.0123063.g001){ref-type="fig"}).

![*Eco*RI, *Eco*RV and *Bam*HI restriction profiles of purified IncL/M plasmid DNAs, analyzed on 0.8% agarose gel.\
DNA on the gel: DNA ladder XV (Roche Diagnostic, GmbH, Mannheim, Germany); *E*. *coli* pKPN-El-Nr.7 plasmid; *E*. *coli* R69 (IncM reference plasmid); plasmid purified from the R69 x pKPN-El-Nr.7 transconjugant.](pone.0123063.g001){#pone.0123063.g001}

Stability experiments performed on transconjugants showed that \>80% of the bacterial cells still showed resistance to both imipenem (marker of the pKPN-El-Nr.7 plasmid) and kanamycin (marker of the R69 plasmid) after three days of sub-culture without antibiotics. Therefore, transconjugants were stable even when cultivated in absence of antibiotic selective pressure. More importantly, these experiments demonstrated that the *bla* ~OXA-48~-positive pKPN-El-Nr.7 plasmid was compatible with the IncM reference plasmid, and therefore it formally belongs to another group than IncM.

Complete nucleotide sequence of IncL/M plasmids: the variable regions conferring antimicrobial resistance {#sec018}
---------------------------------------------------------------------------------------------------------

The complete sequences of the four IncL/M plasmids showed that R69, R471, p202c, and pKPN-E1.Nr.7 were 78,899 bp, 86,747 bp, 79,505 bp and 63,581 bp length, respectively ([Fig 2](#pone.0123063.g002){ref-type="fig"}). In R471 and R69, the ampicillin resistance was due to the *bla* ~TEM-1~ gene associated with the Tn*2* transposon in R471 and Tn*1* in R69, both flanked by the Tn*1696*-like *mer* operon conferring resistance to mercuric ions. R471 contains a complete Tn*402*-like transposon, including the *tni*, *tniB*, *tniC*, *tniR* and *tniM* genes. The tetracycline resistance on R69 was due to the presence of a complete Tn*10* composite transposon containing the *tetR*, *tetA*(B), *tetC*, *tetD* genes flanked by IS*10*. The kanamycin resistance determinant consisted of the Tn*6023* composite transposon, containing the IS*26*-*aphA*---IS*26* module ([Fig 2](#pone.0123063.g002){ref-type="fig"}).

![Major structural features of IncM and IncL plasmids.\
p202c, R69, R471 and pKPN-El-Nr.7 plasmids sequenced in this study are compared with pNDM-OM from *K*. *pneumoniae* 601 \[[@pone.0123063.ref007]\] and pEL60 \[[@pone.0123063.ref026]\]. In the in scale schematic representation, the open reading frames identified in the sequence are represented with arrows of different colors: the *tra* and *trb* transfer loci are in green; the *traX*, *traY*, *excA* entry exclusion genes of the IncM type are in purple, whereas those of the IncL type are in pale blue; resistance genes are in red; transposon-related genes \[*tnpA*, *tnpR*, *tnpM*\], insertion sequences, integrase and resolvase genes are in yellow; the replicase gene is in blue; partitioning genes, toxin-antitoxin and other stabilization systems are in brown; additional genes of unknown function are in white. The line above each plasmid represents the core genome used in comparative analysis.](pone.0123063.g002){#pone.0123063.g002}

The variable region of plasmid p202c contained the *bla* ~SHV-5~ gene and the In-t3 class 1 integron carrying the *aacA4*, *aacC1*, orfP, orfQ, *aadA1* gene cassettes, whose *intI1* gene was truncated by the IS*26* insertion \[[@pone.0123063.ref003], [@pone.0123063.ref023]\]. On this plasmid, the Tn*1696 merA* operon and the ΔTn*1721* transposon carrying the tetracycline resistance gene *tetA*(A) were also identified ([Fig 2](#pone.0123063.g002){ref-type="fig"}).

pKPN-El-Nr.7 showed 100% nucleotide identity with the scaffold of other previously sequenced plasmids carrying the *bla* ~OXA-48~ gene. The carbapenemase gene was mobilized by the Tn*1999*.*2* transposon, including the IS1R element integrated in the IS*1999* located upstream of the *bla* ~OXA-48~ gene \[[@pone.0123063.ref024]\]. No resistance genes other than *bla* ~OXA-48~ were identified on this plasmid, as previously described for the pOXA-48 plasmid and its relatives ([Table 1](#pone.0123063.t001){ref-type="table"}).

Core genome of IncL/M plasmids: designation of separate IncL and IncM plasmid families {#sec019}
--------------------------------------------------------------------------------------

BLASTN comparative analysis was performed on the 4 plasmids sequenced in this study and 13 fully sequenced plasmids available in GenBank ([Table 1](#pone.0123063.t001){ref-type="table"}). The most conserved part of the IncL/M plasmid backbone encoded the transfer loci (*tra*), the replicon (the *repA* replicase gene was highly conserved among L and M plasmids, showing \>99% nucleotide identity), the partitioning module (*parA*, *parB*), and a large number of hypothetical proteins \[[@pone.0123063.ref004], [@pone.0123063.ref025], [@pone.0123063.ref026]\]. The exclusion system (*excA*, *traY*) and relaxase (*traX*) genes were present in all plasmids, but showed diverging sequences. Toxin-antitoxin systems, *mucA-mucB* genes and resistance determinants were not present in all plasmids ([Fig 2](#pone.0123063.g002){ref-type="fig"}).

DNA sequences corresponding to regions shared by all plasmids were jointed to produce a co-linear sequence of approximately 38 Kb representing the core genome of the IncL/M plasmids ([Table 1](#pone.0123063.t001){ref-type="table"}).

The comparative analysis demonstrated high level of DNA homology (overall nucleotide identity of approximately 94%). However, the homology tree clearly revealed the presence of two branches, suggesting the presence of two different plasmid backbones (IncL and IncM; [Fig 3](#pone.0123063.g003){ref-type="fig"}). This division was evident comparing ExcA, TraY, and TraX proteins (35%, 59%, and 75% amino acid identity, respectively) ([Fig 4](#pone.0123063.g004){ref-type="fig"}).

![Homology trees of the IncL and IncM core genomes.\
Core genomes contain the entire scaffold, excluding antimicrobial resistance determinants and genes that were not present in all the plasmids under study. The percentage of nucleotide identity among the compared plasmid core genomes is shown on each branch of the trees. Panels highlight the IncM and IncL branch separation on the tree. The plasmids positive for the *bla* ~OXA-48~ gene are highlighted by a pale blue panel.](pone.0123063.g003){#pone.0123063.g003}

![Homology trees of the ExcA, TraX, TraY protein sequences.\
The deduced protein sequences of the proteins from each respective plasmid were downloaded from the GenBank or deduced from the DNA sequences of plasmids performed in this study. The percentage of amino acid identity among the compared protein sequences is shown on each branch of the trees. Plasmids positive for the *bla* ~OXA-48~ gene are highlighted by pale blue panels.](pone.0123063.g004){#pone.0123063.g004}

The *inc*RNA, encoding the antisense RNA regulating the *repA* gene expression, has been described as the molecular base of the incompatibility behavior of plasmids belonging to the IncFII-complex, also including IncFII, IncI, IncK, IncB/O and IncL/M \[[@pone.0123063.ref027]\]. The *inc*RNA of the IncL/M plasmids demonstrated high heterogeneity. In particular, three major branches were observed by phylogenetic analysis: one corresponding to IncL and two belonging to IncM ([Fig 5](#pone.0123063.g005){ref-type="fig"}).

![Phylogenetic tree and nucleotide sequence alignment of the major stem-and-loop *inc*RNA of IncL and IncM plasmid.\
The *inc*RNA sequences were downloaded from the GenBank or identified in plasmids sequenced in this study. The unrooted phylogenetic tree inferred the evolutionary relationships among the various *inc*RNAs based upon similarities and differences in their nucleotide sequences. The part of the phylogeny tree corresponding to plasmids positive for the *bla* ~OXA-48~ gene is highlighted by pale blue panels. In the panel showing the nucleotide alignment, the residues showing 100% identity have been shaded. The white parts of the alignment show the mismatches identified among the IncL and IncM *inc*RNA sequences.](pone.0123063.g005){#pone.0123063.g005}

IncL plasmids {#sec020}
-------------

This study assigns pOXA-48 and its relatives to the IncL group. These plasmids show unique exclusion system and *inc*RNA sequences, which suggest broad compatibility with other plasmids, including the more closely related IncM. The genetic analysis of plasmid DNA sequences supported the experimental evidence obtained by conjugation, demonstrating that pOXA-48 is fully compatible with the IncM R69 plasmid.

The analysis suggests an evolutionary model in which all IncL/M-type plasmids have diverged from a common ancestor through the acquisition of different entry exclusion systems and relaxases and differentiation of the *inc*RNA determinant in the replicon. The evolution process also involved the integration of the *bla* ~OXA-48~ mobile element conferring carbapenem resistance. It has been demonstrated that the integration of Tn*1999* in the *tir* gene increases the conjugation performance of pOXA-48 \[[@pone.0123063.ref028]\]. These peculiar conjugative features may explain the great success and the current worldwide spread of the pOXA-48-like plasmids.

IncM plasmids {#sec021}
-------------

Plasmids pNDM-OM, pCTX-M-3, pCTXM-360, pNDM-HK, pEl1573, pNE1280, p202c and pEL60 were all highly homologous to R69 and are here designated as IncM members. IncM plasmids show the same backbone but substantially differ in resistance modules ([Table 1](#pone.0123063.t001){ref-type="table"}, [Fig 2](#pone.0123063.g002){ref-type="fig"}). The unrooted phylogenetic tree obtained comparing the *inc*RNA sequences suggested that two types of IncM replicons here designated as M1 and M2 exist ([Fig 5](#pone.0123063.g005){ref-type="fig"}). To check the incompatibility behavior of IncM1 and IncM2 plasmids, conjugation assays were performed crossing R69 (IncM1) with pNDM-OM (IncM2). Transconjugants were not obtained in our conditions (limit of detection lower that 1 x 10^-6^), on LB agar plates containing tetracycline (marker for R69) and imipenem (marker for pNDM-OM). This result was expected because of the presence on both plasmids of the same entry exclusion ExcA and TraY proteins (99% amino acid identity between IncM1 and IncM2). The entry exclusion system is efficiently preventing the conjugation among IncM1 and IncM2 plasmids. However, the divergence of the *inc*RNA is an interesting marker for plasmid typing to identify related lineages within the IncM group.

PCR-Based Replicon Typing (PBRT) of the IncL and IncM groups {#sec022}
------------------------------------------------------------

Since the epidemiological relevance of the members of these plasmid families and the difficulty to distinguish correctly IncM and IncL plasmids by the current methods, the PBRT method has been updated. Using the former PBRT version, IncM plasmids were typable but not those IncL and pOXA-48-like. This was due to the forward primer which was designed considering only the *excA* gene of the IncM plasmid R69 but not that of IncL plasmids (e.g., R471) \[[@pone.0123063.ref018]\]. Recently, it has been proposed to use the *repA*, *parA* and *traU* genes as markers for the detection of all IncL/M plasmids \[[@pone.0123063.ref009]\], but these primers are not able to differentiate between the different IncL/M groups. Therefore, two new forward primers have been designed on the *excA* gene of the IncL \[L- FW\] and IncM plasmid types \[M-FW\], respectively. These primers are used with a unique reverse primer \[L/M- RV\], targeting the highly conserved *repA* gene of both IncL and IncM plasmids.

Based on the new primer strategy, the new PBRT scheme demonstrated 100% specificity and sensitivity in the detection and discrimination of the IncL and IncM replicons. The specificity of this test was verified on 20 plasmids belonging to IncA/C, IncFIIK, IncF, IncHI1, IncHI2, IncI1, IncI2, IncN, IncT, IncX2, IncX1, IncU groups and on 6 belonging to the former IncL/M group ([Table 2](#pone.0123063.t002){ref-type="table"}) \[[@pone.0123063.ref029]--[@pone.0123063.ref044]\].

10.1371/journal.pone.0123063.t002

###### PCR-Based Replicon Typing (PBRT) for IncL and IncM plasmids: list of plasmids used for the specificity assay.

![](pone.0123063.t002){#pone.0123063.t002g}

  Plasmid name   Reference                    Incompatibility group previously assigned by conjugation and/or PBRT   PBRT IncL   PBRT IncM
  -------------- ---------------------------- ---------------------------------------------------------------------- ----------- -----------
  R69            \[[@pone.0123063.ref019]\]   IncL/M                                                                 negative    positive
  p202c          \[[@pone.0123063.ref003]\]   IncL/M                                                                 negative    positive
  pNDM-OM        \[[@pone.0123063.ref007]\]   IncL/M                                                                 negative    positive
  pKPN-El-Nr.7   \[[@pone.0123063.ref020]\]   IncL/M                                                                 positive    negative
  R471           \[[@pone.0123063.ref016]\]   IncL/M                                                                 positive    negative
  Sk-1           \[[@pone.0123063.ref029]\]   IncL/M                                                                 positive    negative
  p2039          \[[@pone.0123063.ref030]\]   IncA/C                                                                 negative    negative
  R387           \[[@pone.0123063.ref031]\]   IncK                                                                   negative    negative
  366-D2         \[[@pone.0123063.ref032]\]   IncFIme                                                                negative    negative
  R100           \[[@pone.0123063.ref032]\]   IncFII                                                                 negative    negative
  LS6            \[[@pone.0123063.ref033]\]   IncFIIK1                                                               negative    negative
  pKPN3-IT       \[[@pone.0123063.ref034]\]   IncFIIK2                                                               negative    negative
  R6k            \[[@pone.0123063.ref035]\]   IncX2                                                                  negative    negative
  pOLA52         \[[@pone.0123063.ref036]\]   IncX1                                                                  negative    negative
  pRA3           \[[@pone.0123063.ref037]\]   IncU                                                                   negative    negative
  172.23(T)      \[[@pone.0123063.ref037]\]   IncR                                                                   negative    negative
  pOXA-181       \[[@pone.0123063.ref038]\]   IncT                                                                   negative    negative
  R46            \[[@pone.0123063.ref039]\]   IncN                                                                   negative    negative
  p1358          \[[@pone.0123063.ref037]\]   IncI1-α                                                                negative    negative
  R483           \[[@pone.0123063.ref018]\]   IncI1-α                                                                negative    negative
  R621a          \[[@pone.0123063.ref018]\]   IncI1-γ                                                                negative    negative
  pNDM-MAR       \[[@pone.0123063.ref040]\]   IncH-like                                                              negative    negative
  R478           \[[@pone.0123063.ref041]\]   IncHI2                                                                 negative    negative
  759-D          \[[@pone.0123063.ref042]\]   IncHI2-FII-FIB                                                         negative    negative
  R27            \[[@pone.0123063.ref043]\]   IncHI1                                                                 negative    negative
  pEQ2           \[[@pone.0123063.ref044]\]   IncHI1-X1                                                              negative    negative

The identification of the IncM1 and IncM2 sub-types can be performed by sequencing the IncM PBRT amplicon obtained as described above, using the L/M-RV primer. In fact, this amplicon includes the *inc*RNA sequence discriminating the M1 and M2 replicons.

Conclusions {#sec023}
===========

The IncM pCTX-M-3 plasmid exhibits very broad host-range, including α-, β- and γ-proteobacteria, able to replicate in *Agrobacterium tumefaciens*, *Ralstonia eutropha*, and *Pseudomonas aeruginosa* \[[@pone.0123063.ref025]\]. It was also demonstrated that pOXA-48 replicates in *Shewanella oneidensis*, a species close to the progenitor of the *bla* ~OXA-48~ gene \[[@pone.0123063.ref045]\]. These findings suggest that both IncL and IncM plasmids may constitute an important interspecies vehicle for the dissemination of life-threatening resistance genes.

Conjugation and whole plasmid sequencing demonstrated that IncL and IncM plasmids, each carrying specific ExcA-TraY entry exclusion proteins, relaxases and incompatibility determinants, constitute the currently titled IncL/M family. The IncL group includes the reference plasmid R471, as well as the pOXA-48-like and R830b plasmids. The heterogeneity of the IncM group consisted in variable resistance modules and in the presence of divergent *inc*RNAs. However, conjugation between isolates carrying members of the IncM group was impaired by the inhibitory interaction of the exclusion system, which is highly conserved among all the IncM plasmids. IncL/M represents a nice example of plasmid evolution and differentiation, explaining the different levels of negative controls regulating the incompatibility behavior of highly related plasmids. The divergence of the *inc*RNA sequence is likely the first step for the differentiation of a new Inc group, but the presence of almost identical exclusion systems may still interfere with conjugation. The acquisition of a divergent exclusion system, such as that identified on the IncL plasmids, is the further step required to obtain full compatibility among related plasmids.
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